Predictive validity of interleukin 6 (IL-6) for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study.

ABSTRACT:

Objectives

To investigate the serum IL-6 levels and their rate of change in predicting the mortality of critically ill patients with COVID-19 in Vietnam.

Design

A single-centre, cross-sectional study.

Setting

An Intensive Care Centre for the Treatment of Critically Ill Patients with COVID-19 in Ho Chi Minh City, Vietnam.

Participants

We included patients aged 18 years or older who were critically ill with COVID-19 and presented to the study centre from 30 July 2021 to 15 October 2021. We excluded patients who did not have serum IL-6 measurements between admission and the end of the first day.

Primary outcome measures

The primary outcome was hospital all-cause mortality.

Results

Of 90 patients, 41.1% were men, the median age was 60.5 years (Q1-Q3:

SUBMITTER: Nguyen CV 

PROVIDER: S-EPMC11628983 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature